The Discounted Cash Flow (DCF) valuation of HTG Molecular Diagnostics Inc (HTGM) is (1,214. USD. With the latest stock price at 0.48 USD, the upside of HTG Molecular Diagnostics Inc based on DCF is -253138.5%.

Is HTGM a buy or a sell?

Based on the latest price of 0.48 USD and our DCF valuation, HTG Molecular Diagnostics Inc (HTGM) is a sell. Selling HTGM stocks now will result in a potential gain of 253138.5%.

Note: valuation result may not be accurate due to the company's negative earnings.

	Range	Selected
WACC / Discount Rate	4.2% - 7.1%	5.7%
Long-term Growth Rate	3.0% - 4.0%	3.5%
Fair Price	(10,525.32) - (649.84)	(1,214.58)
Upside	-2192875.5% - -135482.9%	-253138.5%

0.48 USD

Stock Price

(1,214. USD

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

HTGM DCF Valuation: Revenue & Expenses Forecast

(USD in millions)		Projections

	12-2022	12-2023	12-2024	12-2025	12-2026	12-2027

Revenue	6	6	16	18	21	25
% Growth	29%	1%	145%	18%	16%	15%

Cost of goods sold	(5)	(4)	(10)	(11)	(12)	(14)
% of Revenue	72%	68%	65%	62%	58%	56%

Selling, G&A expenses	(16)	(16)	(39)	(46)	(53)	(61)
% of Revenue	249%	249%	249%	249%	249%	249%

Research & Development	(7)	(7)	(17)	(20)	(23)	(26)
% of Revenue	107%	107%	107%	107%	107%	107%

Net interest & other expenses	(1)	(1)	(2)	(2)	(3)	(3)
% of Revenue	12%	12%	12%	12%	12%	12%

Tax expense	(0)	0	0	0	0	0
Tax rate	0%	0%	0%	0%	0%	0%

Net profit	(22)	(21)	(52)	(61)	(69)	(79)
% Margin	-339%	-335%	-332%	-329%	-325%	-323%